Smart and Personalized Migraine Treatment

Neurawave is a Swedish company focused on developing innovative solutions for migraine relief. Neurawave's vision is to eliminate all migraine pain. Our mission is to give everyone with migraine control over their migraine and their lives.

Migraine – A Public Health Issue

img

According to the World Health Organization (WHO), headache disorders affected approximately 40% of the global population in 2021. Migraine is a common type of headache disorder that can affect both adults and children. An alternative to medication is needed, as its effect can diminish over time or not work at all for everyone.

  • 1 in 7

    People globally

    Migraine affects ~15% of the world's population — more commonly women than men.

  • Genetic

    Strong hereditary link

    Family history significantly raises the risk, especially for migraine with aura.

  • 25%

    Experience aura

    Visual disturbances, flashes of light, or temporary vision loss before the headache.

✓ Now available — live in Chile since April 2026

Relief aHead – Your Personal Solution for Migraine

A complete ecosystem of hardware and software. Paying customers in Chile, 10,000+ app downloads, and available on Google Play.

Relief aHead app and device
Download on the App StoreGet it on Google Play
Order now

Available in Chile — more markets coming

Relief aHead home view

Overview & Predictions

See your migraine risk in real time and get personalized insights

Relief aHead treatment view

Treatment

Start and follow your treatment with a single tap

Product availability and intended use may vary between markets. See the respective webshop and app store for details. Always consult a healthcare professional before making medical decisions.

Traction

Launched in Chile in April 2026 with paying customers, 10,000+ app downloads, and growing.

10,000+App DownloadsiOS & Android
April 2026First SalePaying customers in Chile
SwedenSwedish InnovationDesigned & developed in Kalmar
ReliviaOur ProductIntelligent nerve stimulation for migraine relief

Our Vision – Accessible Migraine Relief for Everyone

Relief aHead device on forehead

We want to make migraine treatment simple and accessible for everyone. Our vision is to combine smart technology with personalized care so that more people can find relief and gain control over their migraine.

  • Personalized treatment tailored to your unique needs and preferences.

  • Scientifically proven nerve stimulation for both preventive treatment and acute relief.

  • AI-driven prediction that anticipates migraine attacks before the pain begins.

Roadmap

Where we've been, where we are, and where the investment goes.

  1. ✓
    Done

    Product built & app launched

    Hardware and software developed from the ground up. App is live on Google Play and the App Store in Chile.

  2. ✓
    April 2026 — Done

    First sale — Chile launch

    Relief aHead commercially available in Chile. Paying customers, 10,000+ app downloads, one active market.

  3. →
    Now — In progress

    Growing user base & fundraising

    Scaling Chile operations, onboarding new users, and raising the round that funds EU regulatory clearance.

  4. 1
    Next

    Clinical study — Karolinska University Hospital

    Partnered clinical study to generate the evidence base required for EU regulatory approval.

  5. 2
    Next

    CE marking under MDR

    EU medical device certification — the regulatory milestone that unlocks the full European market.

  6. 3
    Next

    EU launch

    Commercial rollout across European markets, starting with the Nordics. 40M+ migraine sufferers in the EU.

eHealth Arena
eHealth Arena
Kalmar Science Park
Kalmar Science Park
Linnéuniversitetet
Linnéuniversitetet
Region Kalmar County
Region Kalmar County
DigitalWell Arena
DigitalWell Arena
SmiLe Venture Hub
SmiLe
Investment Readiness Process: IRP
IRP
Kick Capital
Kick Capital
Karolinska University Hospital

Meet our team

We are a dedicated team with expertise in medical technology, software development, innovation and AI, working from Kalmar to develop tomorrow's solutions for migraine. See open positions

Latest News

Relief aHead takes part in Summit País Digital 2026 in Santiago

Relief aHead is at Summit País Digital 2026 in Santiago, Chile, on October 6–8, the year Sweden is the guest country. Paula Vivar Montero represents us at our table.

October 6, 2026

Meet us at TechHeads 2026 at Kalmar Castle

Neurawave and Relief aHead are in the exhibition area at TechHeads 2026 at Kalmar Castle on October 1. Come and talk apps, innovation, manufacturing and Chile.

September 30, 2026

Neurawave launches Relief aHead and Relivia in Chile

After months of work, Neurawave has launched its brand Relief aHead and the product Relivia in Chile, its first market outside Sweden.

April 7, 2026

Contact us

We look forward to hearing from you

Whether you have questions, ideas, are interested in working with us, or want to book a meeting — don't hesitate to reach out.

Address: Bredbandet 1, Varvsholmen, Kalmar

Email: contact@neurawave.se